
Freeline Therapeutics Holdings (FRLN)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy FRLN Stock
Start investing in FRLN
About Freeline Therapeutics Holdings (FRLN)
Market cap | $28.24M |
Today's volume | — |
Revenue (TTM) | — |
Avg. daily volume | — |
EBITDA (TTM) | — |
Open | — |
Price / earnings ratio | — |
Today's range | — |
Debt / equity | — |
52 week range | $6.48 - $6.48 |
5 year debt / equity | — |
Beta (LTM) | — |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | — |
Ex-dividend date | — |
Next earnings | Dec 1, 2023 |
Dividend payable date | — |
FRLN Stock Rating
FRLN Stock News
View all



Frequently Asked Questions (FAQ)
How to buy FRLN stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in FRLN stock
Navigate to the Explore page. Then, type FRLN into the search bar. When you see FRLN stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased FRLN stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Freeline Therapeutics Holdings Stock Earnings
The value each FRLN share was expected to gain vs. the value that each FRLN share actually gained.
FRLN (FRLN) reported Q3 2023 earnings per share (EPS) of -$0.18, beating estimates of -$0.71 by 74.65%. In the same quarter last year, FRLN's earnings per share (EPS) was -$3. FRLN is expected to release next earnings on 12/01/2023, with an earnings per share (EPS) estimate of $0.